In vitro inhibition of CYP2D6 activity by fenfluramine.

被引：0
|
作者：
Marcucci, K
Gotschall, R
Kearns, GL
Leeder, JS
机构：
[1] Childrens Mercy Hosp, Sect Clin Pharmacol & Exp Ther, Kansas City, MO 64108 USA
[2] Childrens Mercy Hosp, NICHD, PPRU, Kansas City, MO 64108 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80099-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI99
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [41] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [42] CYP2D6 genotypes in a Japanese population:: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10
    Nishida, Y
    Fukuda, T
    Yamamoto, I
    Azuma, J
    PHARMACOGENETICS, 2000, 10 (06): : 567 - 570
  • [43] Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population
    Cai, W. M.
    Chen, B.
    Zhang, W. X.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) : 95 - 98
  • [44] CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status
    Gaedigk, A
    Bradford, LD
    Alander, SW
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 563 - 569
  • [45] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    F. Gressier
    C. Verstuyft
    P. Hardy
    L. Becquemont
    E. Corruble
    Journal of Neural Transmission, 2015, 122 : 35 - 42
  • [46] The impact of CYP2D6*41 on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva
    Jin, Ye
    Zhang, Shuquan
    Hu, Pei
    Zheng, Xin
    Guan, Xiaoduo
    Chen, Rui
    Zhang, Shuyang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Classic antihistamines inhibit CYP2D6 in vitro.
    Hamelin, BA
    Gravel, A
    Turgeon, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII53 - PII53
  • [48] Effect of CYP2D6 variants on venlafaxine metabolism in vitro
    Zhan, Yun-Yun
    Liang, Bing-Qing
    Wang, Hao
    Wang, Zhen-He
    Weng, Qing-Hua
    Dai, Da-Peng
    Cai, Jian-Ping
    Hu, Guo-Xin
    XENOBIOTICA, 2016, 46 (05) : 424 - 429
  • [49] CYP2D6 multiallelism
    Daly, AK
    Steen, VM
    Fairbrother, KS
    Idle, JR
    CYTOCHROME P450, PT B, 1996, 272 : 199 - 210
  • [50] Metabolic activity of dextromethorphan O-demethylation in healthy Japanese volunteers carrying duplicated CYP2D6 genes:: duplicated allele of CYP2D6*10 does not increase CYP2D6 metabolic activity
    Ishiguro, A
    Kubota, T
    Ishikawa, H
    Iga, T
    CLINICA CHIMICA ACTA, 2004, 344 (1-2) : 201 - 204
12345